These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20130845)

  • 21. Intracellular Ca(2+) oscillations generated via the extracellular Ca(2+)-sensing receptor (CaSR) in response to extracellular Ca(2+) or L-phenylalanine: Impact of the highly conservative mutation Ser170Thr.
    Young SH; Rey O; Rozengurt E
    Biochem Biophys Res Commun; 2015 Nov; 467(1):1-6. PubMed ID: 26431875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcimimetic inhibits late-stage cyst growth in ADPKD.
    Gattone VH; Chen NX; Sinders RM; Seifert MF; Duan D; Martin D; Henley C; Moe SM
    J Am Soc Nephrol; 2009 Jul; 20(7):1527-32. PubMed ID: 19423689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein kinase C-mediated phosphorylation of the calcium-sensing receptor is stimulated by receptor activation and attenuated by calyculin-sensitive phosphatase activity.
    Davies SL; Ozawa A; McCormick WD; Dvorak MM; Ward DT
    J Biol Chem; 2007 May; 282(20):15048-56. PubMed ID: 17376781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel cation-sensing mechanism in osteoblasts is a molecular target for strontium.
    Pi M; Quarles LD
    J Bone Miner Res; 2004 May; 19(5):862-9. PubMed ID: 15068510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism.
    Nagano N
    Pharmacol Ther; 2006 Mar; 109(3):339-65. PubMed ID: 16102839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE-/-) mice.
    Ivanovski O; Nikolov IG; Joki N; Caudrillier A; Phan O; Mentaverri R; Maizel J; Hamada Y; Nguyen-Khoa T; Fukagawa M; Kamel S; Lacour B; Drüeke TB; Massy ZA
    Atherosclerosis; 2009 Jul; 205(1):55-62. PubMed ID: 19118829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of divalent cations and of a calcimimetic on adrenocorticotropic hormone release in pituitary tumor cells.
    Ferry S; Chatel B; Dodd RH; Lair C; Gully D; Maffrand JP; Ruat M
    Biochem Biophys Res Commun; 1997 Sep; 238(3):866-73. PubMed ID: 9325183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium sensing receptor expression in ovine amniotic fluid mesenchymal stem cells and the potential role of R-568 during osteogenic differentiation.
    Di Tomo P; Pipino C; Lanuti P; Morabito C; Pierdomenico L; Sirolli V; Bonomini M; Miscia S; Mariggiò MA; Marchisio M; Barboni B; Pandolfi A
    PLoS One; 2013; 8(9):e73816. PubMed ID: 24040082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ca(2+) mobilization through dorsal root ganglion Ca(2+)-sensing receptor stably expressed in HEK293 cells.
    Awumey EM; Howlett AC; Putney JW; Diz DI; Bukoski RD
    Am J Physiol Cell Physiol; 2007 May; 292(5):C1895-905. PubMed ID: 17267550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Calcium receptor/calcium-sensing receptor].
    Nagano N
    Nihon Yakurigaku Zasshi; 2006 Sep; 128(3):188-90. PubMed ID: 17139821
    [No Abstract]   [Full Text] [Related]  

  • 31. Expression of calcium-sensing receptor in quail granulosa explants: a key to survival during folliculogenesis.
    Diez-Fraile A; Mussche S; Vanden Berghe T; Espeel M; Vandenabeele P; D'Herde KG
    Anat Rec (Hoboken); 2010 May; 293(5):890-9. PubMed ID: 20186967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcimimetics: therapeutic potential in hyperparathyroidism.
    Cohen A; Silverberg SJ
    Curr Opin Pharmacol; 2002 Dec; 2(6):734-9. PubMed ID: 12482739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The calcimimetic R-568 increases vitamin D receptor expression in rat parathyroid glands.
    Rodriguez ME; Almaden Y; Cañadillas S; Canalejo A; Siendones E; Lopez I; Aguilera-Tejero E; Martin D; Rodriguez M
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1390-5. PubMed ID: 17200160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biased allosteric modulation at the CaS receptor engendered by structurally diverse calcimimetics.
    Cook AE; Mistry SN; Gregory KJ; Furness SG; Sexton PM; Scammells PJ; Conigrave AD; Christopoulos A; Leach K
    Br J Pharmacol; 2015 Jan; 172(1):185-200. PubMed ID: 25220431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulation of cell proliferation by calcium and a calcimimetic compound.
    Mailland M; Waelchli R; Ruat M; Boddeke HG; Seuwen K
    Endocrinology; 1997 Sep; 138(9):3601-5. PubMed ID: 9275041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coupling of calcium receptors to inositol phosphate and cyclic AMP generation in mammalian cells and Xenopus laevis oocytes and immunodetection of receptor protein by region-specific antipeptide antisera.
    Chang W; Pratt S; Chen TH; Nemeth E; Huang Z; Shoback D
    J Bone Miner Res; 1998 Apr; 13(4):570-80. PubMed ID: 9556057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations.
    Makita N; Sato J; Manaka K; Shoji Y; Oishi A; Hashimoto M; Fujita T; Iiri T
    Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5443-8. PubMed ID: 17372216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor.
    Wada M; Furuya Y; Sakiyama J; Kobayashi N; Miyata S; Ishii H; Nagano N
    J Clin Invest; 1997 Dec; 100(12):2977-83. PubMed ID: 9399943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homology modeling of the transmembrane domain of the human calcium sensing receptor and localization of an allosteric binding site.
    Miedlich SU; Gama L; Seuwen K; Wolf RM; Breitwieser GE
    J Biol Chem; 2004 Feb; 279(8):7254-63. PubMed ID: 14660633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcimimetics and hyperparathyroidism.
    Krebs LJ
    Curr Opin Investig Drugs; 2004 Oct; 5(10):1080-5. PubMed ID: 15535429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.